Wealthspire Advisors (New York)’s Annovis Bio ANVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.7K | Sell |
10,000
-50
| -0.5% | -$109 | ﹤0.01% | 842 |
|
|
2025
Q1 | $15.1K | Hold |
10,050
| – | – | ﹤0.01% | 784 |
|
|
2024
Q4 | $50.6K | Buy |
10,050
+50
| +0.5% | +$252 | ﹤0.01% | 774 |
|
|
2024
Q3 | $80.6K | Hold |
10,000
| – | – | ﹤0.01% | 729 |
|
|
2024
Q2 | $57.6K | Hold |
10,000
| – | – | ﹤0.01% | 648 |
|
|
2024
Q1 | $119K | Sell |
10,000
-990
| -9% | -$11.8K | ﹤0.01% | 622 |
|
|
2023
Q4 | $206K | Buy |
10,990
+990
| +10% | +$18.5K | ﹤0.01% | 613 |
|
|
2023
Q3 | $94.9K | Hold |
10,000
| – | – | ﹤0.01% | 580 |
|
|
2023
Q2 | $143K | Hold |
10,000
| – | – | ﹤0.01% | 542 |
|
|
2023
Q1 | $154K | Buy |
+10,000
| New | +$154K | ﹤0.01% | 510 |
|
|
2021
Q4 | – | Sell |
-7,500
| Closed | -$238K | – | 540 |
|
|
2021
Q3 | $238K | Buy |
7,500
+2,500
| +50% | +$79.3K | ﹤0.01% | 505 |
|
|
2021
Q2 | $428K | Sell |
5,000
-5,000
| -50% | -$428K | 0.01% | 240 |
|
|
2021
Q1 | $279K | Buy |
+10,000
| New | +$279K | 0.01% | 572 |
|